Indications and practical approach to non-invasive ventilation in acute heart failure
Josep Masip(Consorci Sanitari Garraf), Christian Mueller(Universität Hamburg), W. Frank Peacock, Frank Ruschitzka(Kantonsspital St. Gallen), Gerasimos Filippatos(University General Hospital Attikon), John J.V. McMurray(British Heart Foundation), Michael Christ(Luzerner Kantonsspital), Salvatore DiSomma(Azienda Ospedaliera Sant'Andrea), Alan S. Maisel(Brigham and Women's Hospital), Héctor Bueno, Chris P Gale(University of Leeds), Veli‐Pekka Harjola(University of Helsinki), Louise Cullen(Royal Brisbane and Women's Hospital), Elke Platz(Brigham and Women's Hospital), Maddalena Lettino, Petar Seferović, Alexandre Mebazaa(Délégation Paris 5), Francisco Javier Martín‐Sánchez(Universidad Complutense de Madrid), Òscar Miró(Fundació Clínic per a la Recerca Biomèdica), Uwe Zeymer(Klinikum Ludwigshafen), Martín Cowie(Royal Brompton Hospital), Christiaan Vrints(University of Antwerp), Múcio Tavares(Universidade de São Paulo), Susanna Price(St Thomas' Hospital)
Cited by 229
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k